American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
PepsiCo
PEP
|
+$227M |
| 2 |
Fortive
FTV
|
+$202M |
| 3 |
Charles Schwab
SCHW
|
+$182M |
| 4 |
American Water Works
AWK
|
+$140M |
| 5 |
Medtronic
MDT
|
+$128M |
Top Sells
| 1 |
MXIM
Maxim Integrated Products
MXIM
|
+$400M |
| 2 |
Cummins
CMI
|
+$274M |
| 3 |
Becton Dickinson
BDX
|
+$273M |
| 4 |
Kimberly-Clark
KMB
|
+$248M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$243M |
Sector Composition
| 1 | Technology | 21.68% |
| 2 | Healthcare | 15.63% |
| 3 | Consumer Discretionary | 13.99% |
| 4 | Financials | 13.61% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Target
TGT
$41.6B
| $80.8M | 0.07% |
513,284
-451,683
| -47% | -$71.1M |
|
|
NBIS
277
Nebius Group N.V. Class A Ordinary Shares
NBIS
$21.3B
| $79.9M | 0.07% |
1,225,107
-11,911
| -1% | -$777K |
|
|
ENV
278
DELISTED
ENVESTNET, INC.
ENV
| $79.7M | 0.07% |
1,032,741
+33,866
| +3% | +$2.61M |
|
279
Peloton Interactive
PTON
$3.12B
| $79.3M | 0.07% |
799,533
-120,983
| -13% | -$12M |
|
280
Graco
GGG
$14.3B
| $78.4M | 0.07% |
1,277,369
-110,924
| -8% | -$6.81M |
|
|
ABMD
281
DELISTED
Abiomed Inc
ABMD
| $77.2M | 0.07% |
278,627
+45,119
| +19% | +$12.5M |
|
282
IBM
IBM
$239B
| $77M | 0.07% |
661,641
-140,238
| -17% | -$16.3M |
|
|
IMMU
283
DELISTED
Immunomedics Inc
IMMU
| $76.6M | 0.07% |
900,980
-1,863,220
| -67% | -$158M |
|
284
Avantis Emerging Markets Equity ETF
AVEM
$12.7B
| $76.5M | 0.07% |
1,478,531
-25,946
| -2% | -$1.34M |
|
285
Compass Diversified
CODI
$528M
| $76.2M | 0.07% |
3,998,648
+45,238
| +1% | +$862K |
|
286
Chewy
CHWY
$14.9B
| $75.4M | 0.07% |
1,375,307
+778,906
| +131% | +$42.7M |
|
287
Tandem Diabetes Care
TNDM
$836M
| $75.2M | 0.07% |
662,216
-31,284
| -5% | -$3.55M |
|
288
Globant
GLOB
$2.58B
| $74.3M | 0.07% |
414,495
-13,929
| -3% | -$2.5M |
|
289
Las Vegas Sands
LVS
$37.4B
| $72.8M | 0.06% |
1,561,283
-1,241,025
| -44% | -$57.9M |
|
290
Repligen
RGEN
$6.72B
| $72.5M | 0.06% |
491,698
+469,434
| +2,108% | +$69.3M |
|
291
Baker Hughes
BKR
$46.3B
| $71.9M | 0.06% |
5,406,693
+255,260
| +5% | +$3.39M |
|
292
Spectrum Brands
SPB
$1.3B
| $71.7M | 0.06% |
1,253,524
-171,878
| -12% | -$9.82M |
|
293
Expedia Group
EXPE
$26.7B
| $70.9M | 0.06% |
772,829
-417,370
| -35% | -$38.3M |
|
294
SelectQuote
SLQT
$363M
| $70.5M | 0.06% |
3,482,326
+1,022,773
| +42% | +$20.7M |
|
295
Ameren
AEE
$27.1B
| $70.3M | 0.06% |
889,105
+18,916
| +2% | +$1.5M |
|
296
Fastly
FSLY
$1.16B
| $68.9M | 0.06% |
735,546
-712,058
| -49% | -$66.7M |
|
297
Ryanair
RYAAY
$31.7B
| $68.4M | 0.06% |
2,091,900
+499,670
| +31% | +$16.3M |
|
|
BPMC
298
DELISTED
Blueprint Medicines
BPMC
| $68.2M | 0.06% |
736,039
+33,460
| +5% | +$3.1M |
|
299
Nordson
NDSN
$12.6B
| $66.8M | 0.06% |
348,332
+81
| +0% | +$15.5K |
|
300
CDW
CDW
$22.4B
| $66.3M | 0.06% |
554,296
-331,644
| -37% | -$39.6M |
|